Xcout IntelAlgeta ASA
Algeta ASA was a Norwegian biopharmaceutical company focused on developing targeted radiopharmaceutical cancer treatments. Its leading product, Xofigo (radium-223 dichloride)…
The full profile of Algeta ASA
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Algeta ASA →Already a subscriber? Sign in
Xcout Intel tracks Algeta ASA continuously — this profile deepens as new filings, funding, people and hiring data arrive.